PeraHealth
- Company typePrivate
- Founded2008
- HeadquartersCharlotte, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What PeraHealth does
PeraHealth is a Charlotte, North Carolina-based healthcare technology company founded in 2008 that develops the Rothman Index, an FDA-cleared artificial intelligence predictive analytics system designed to detect early signs of patient deterioration in hospital settings. The platform automatically extracts and analyzes continuously changing clinical measurements from the Electronic Medical Record (EMR), including vital signs, laboratory results, and complete head-to-toe nursing assessments, and uses proprietary algorithms to compute an aggregated score of a patient's overall physiological condition. The company's stated differentiator is detection of subtle deterioration trends up to 24 hours before conventional bedside alarms trigger, with documented clinical outcomes including a 16% mortality reduction at one California hospital and reported identification of 70-80% of code blue patients prior to the event.
PeraHealth's product portfolio comprises three offerings: the core Rothman Index (the underlying patient-condition score), Rothman Index Trend (a population-level surveillance dashboard supporting shift handoffs and multi-disciplinary rounds), and Rothman Index for Pediatrics (specialized algorithms for pediatric patients). The technology is delivered via integration with hospital EMR/EHR systems and can be accessed through a web browser, EHR integration, or a dedicated command center, and is applicable across medical/surgical units, intermediate care, and intensive care locations. The company has accumulated more than 55 peer-reviewed publications supporting the clinical effectiveness of the technology, and the Rothman Index is a registered trademark.
The company operates on an OEM/whitelabel technology licensing model rather than direct enterprise sales. Its primary distribution partner is Spacelabs Healthcare (a wholly owned subsidiary of OSI Systems, Inc., NASDAQ: OSIS), which licenses the Rothman Index from PeraHealth and embeds it within its SaaS predictive analytics portfolio sold to hospitals and health systems globally. Pricing is not publicly disclosed and is set by partner companies rather than PeraHealth directly. The company is privately held, employs between 11 and 50 people, and its most recent disclosed funding event was a $14 million growth round led by Mainsail Partners in January 2017.
PeraHealth firmographics
Firmographics- Name
- PeraHealth
- Legal name
- Spacelabs Healthcare
- Website
- https://perahealth.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
PeraHealth industry classification
Industry- Product category
- Clinical Decision Support / Healthcare Predictive Analytics
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Fall Detection, Safety & Emergency Response (PERS, Smart Home Health Sensors) (HLAHACAG)
Keywords
Where PeraHealth is headquartered
LocationHeadquarters
- HQ city
- Charlotte
- HQ country
- United States
- HQ region
- North America
Markets served
PeraHealth business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Technology Licensing - OEM/Whitelabel: PeraHealth licenses its Rothman Index technology to partners like Spacelabs Healthcare who incorporate it into their product offerings. Revenue is generated through licensing agreements with healthcare equipment and software companies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
PeraHealth product offering
Product offeringCore offering
PeraHealth develops and licenses the Rothman Index, an FDA-cleared AI predictive analytics system that automatically extracts and analyzes clinical data from the EMR — including vital signs, lab results, and head-to-toe nursing assessments — to detect subtle patient deterioration up to 24 hours before alarms sound. The platform is offered as a SaaS portfolio through OEM/whitelabel partners such as Spacelabs Healthcare, covering adult, pediatric, and population-level surveillance use cases for hospitals and health systems.
Product overview
PeraHealth offers the Rothman Index as a unified FDA-cleared AI predictive analytics platform designed for early detection and intervention of patient deterioration. The core Rothman Index product automatically extracts and analyzes clinical measurements from EMR systems, including nursing assessments, to generate an aggregated patient condition score. The platform is offered as SaaS and includes sub-products: Rothman Index Trend (population-level surveillance dashboard supporting care transitions) and Rothman Index for Pediatrics (specialized algorithms for pediatric patients). The system is applicable across medical/surgical units, intermediate care, and intensive care locations.
Differentiator
Problem solved
Functional benefit
Products and services
- Rothman Index
Quantifiable outcome
- 16% decrease in mortality rate at California hospital
- +4 more outcomes
Companies that use PeraHealth
Customer profileSegments1 record
Ideal customer profiles1 record
PeraHealth technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability2 records
Feature3 records
PeraHealth partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Spacelabs HealthcarecoreSpacelabs Healthcare is a key OEM/whitelabel partner that licenses the Rothman Index technology from PeraHealth. Spacelabs incorporates the FDA-cleared AI predictive analytics system into their SaaS portfolio, marketing and distributing it to hospitals and health systems as part of their patient monitoring and analytics offerings.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
PeraHealth competitors and assessment
Company assessmentDirect peers
- Spacelabs Healthcare: Spacelabs Healthcare is PeraHealth's primary OEM distribution partner and embeds the Rothman Index directly in its predictive analytics SaaS portfolio sold to hospitals. Both companies sell into the same hospital early-warning/predictive analytics buyer, making Spacelabs the closest commercial analog even though it is also a partner.
Broad incumbents
- Epic Systems (Deterioration Index): Epic bundles a Deterioration Index natively into its EHR, which competes directly with the Rothman Index for the same nurse-and-physician early-warning workflow. As the dominant hospital EHR vendor, Epic is the single most consequential incumbent competitor for PeraHealth's category.
- GE HealthCare (Mural): GE HealthCare's Mural platform offers hospital-wide patient deterioration and sepsis prediction as part of its broader command-center and patient monitoring suite. It overlaps with PeraHealth's clinical use cases through a much larger installed footprint.
- Philips (IntelliVue & early warning analytics): Philips provides patient monitoring hardware and analytics (IntelliVue and connected care solutions), including early-warning scores for hospitalized patients. It competes with PeraHealth across the same continuous-monitoring and deterioration-detection use cases at a broader portfolio scale.
- Medidata / Medidata AI (early warning modules): Medidata and adjacent Medtronic clinical solutions offer algorithm-driven patient monitoring analytics integrated into hospital surveillance workflows, overlapping with Rothman Index in continuous patient condition scoring.
Emerging players
- Dascena (now Inseparable AI): Dascena/Inseparable AI developed AI algorithms for early detection of patient deterioration, sepsis, and acute kidney injury using EHR data - a head-to-head technical and clinical peer to the Rothman Index in the in-hospital predictive analytics category.
- CLEW Medical: CLEW Medical builds AI-driven predictive analytics for ICU patient deterioration and clinical resource optimization. It targets the same acute-care customer base and similar early-warning use cases that PeraHealth addresses with the Rothman Index.
- Excel Medical Electronics: Excel Medical provides FDA-cleared early-warning software and patient surveillance platforms used in hospital ICUs and step-down units. It competes directly with PeraHealth in the AI-driven patient deterioration detection category.
- Hospital IQ: Hospital IQ applies predictive analytics to hospital operations and clinical decision support. While more operational, it competes for the same analytics-driven decision-making buyer that PeraHealth targets with its deterioration scores.
- EarlySense: EarlySense provides continuous patient monitoring sensors and contact-free deterioration detection technology for hospital and post-acute settings. It offers a different input modality (sensor-based) but targets overlapping deterioration-detection use cases in the same clinical buyer group.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
PeraHealth social profiles
Digital presencePeraHealth compliance and trust
Trust signalCompliance1 record
PeraHealth financial estimates
Financial estimateRevenue estimate
Valuation estimate
PeraHealth leadership team
Management profileNumber of profiles
Profiles5 records
PeraHealth funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PeraHealth M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PeraHealth
What does PeraHealth do?
PeraHealth develops and licenses the Rothman Index, an FDA-cleared AI predictive analytics system that automatically extracts and analyzes clinical data from the EMR — including vital signs, lab results, and head-to-toe nursing assessments — to detect subtle patient deterioration up to 24 hours before alarms sound. The platform is offered as a SaaS portfolio through OEM/whitelabel partners such as Spacelabs Healthcare, covering adult, pediatric, and population-level surveillance use cases for hospitals and health systems.
Is PeraHealth a public or private company?
PeraHealth is a private company. It is classified as venture growth investor backed and is currently operating.
When was PeraHealth founded?
PeraHealth was founded in 2008. It employs 11 to 50 people.
Where is PeraHealth based?
PeraHealth is headquartered in Charlotte, United States, in the North America region.
How does PeraHealth make money?
One revenue line is on record: technology Licensing - OEM/Whitelabel.
Who are PeraHealth's main competitors?
Spacelabs Healthcare is listed as a direct peer. Broad incumbents are Epic Systems (Deterioration Index), GE HealthCare (Mural), Philips (IntelliVue & early warning analytics) and Medidata / Medidata AI (early warning modules). Emerging players are Dascena (now Inseparable AI), CLEW Medical, Excel Medical Electronics, Hospital IQ and EarlySense.
Does PeraHealth have an API?
No public API is recorded for PeraHealth.
What industry is PeraHealth in?
PeraHealth's product category is Clinical Decision Support / Healthcare Predictive Analytics. Its primary akta.pro industry code is HLAHACAG, Fall Detection, Safety & Emergency Response (PERS, Smart Home Health Sensors). Its SIC code is 3841.